DroneShield’s European Pivot and Pentagon Win Face a Defining H2 as ASIC Cloud Lingers
Published on 06/19/2026 at 13:11 | Redaktion boerse-global.de
DroneShield has taken two notable strategic steps — starting European production of its counter-drone systems and sealing a five-year contract with the U.S. Department of Defense — yet the stock remains stuck near oversold territory. The shares trade at €1.64, roughly 55% below the October 2025 peak of €3.65, and have fallen more than 17% since the start of the year. The culprit is not the company’s operations but a regulatory investigation that continues to sap investor confidence.
The inquiry launched by the Australian Securities and Investments Commission (ASIC) on May 12 triggered a single-day sell-off of 16%. Regulators are scrutinising disclosures made between November 1 and November 20, 2025, with particular focus on the week of November 6 to 12. That window coincided with the sale of nearly A$70 million worth of shares by former CEO Oleg Vornik, chairman Peter James, and director Jethro Marks. On November 10, the day those trades were executed, DroneShield issued a press release touting a A$7.6 million contract — only to retract it hours later, calling it a reclassification of existing orders. That sequence sits at the heart of the investigation, and the company has said it cannot predict the outcome.
Institutional investors have been voting with their feet. JPMorgan exited as a substantial shareholder in May, BlackRock followed on May 19, and Citigroup confirmed on June 2 that it no longer holds a material position. The departures have added selling pressure even though the company retains a healthy balance sheet: A$223 million in cash and zero debt.
Should investors sell immediately? Or is it worth buying DroneShield?
Operational momentum, meanwhile, remains strong. On June 2, DroneShield secured a contract with the Joint Interagency Task Force 401 of the U.S. Department of Defense, worth an initial US$19.3 million, with options for an additional US$5.6 million over five years. The company also made its debut at the Eurosatory defence exhibition in Paris, showcasing the first counter-drone systems manufactured in Europe. Those units are built using a contract manufacturing model with a predominantly European supply chain and are technically identical to the Australian version. Production is linked to a partnership announced in March 2026 with an unnamed European manufacturer.
The European push extends to partnerships as well. At Eurosatory, DroneShield announced a collaboration with Dutch tactical-vehicle specialist Defenture to develop mobile counter-drone solutions. The move dovetails with the EU’s Readiness 2030 defence procurement program and the company’s recently opened European headquarters in Amsterdam, signalling a long-term commitment to the region.
DroneShield’s overall pipeline is at record levels. The order book now holds 312 projects with a combined value of A$2.2 billion. First-quarter revenue jumped 121% year on year, and the company has already booked A$155 million in secured revenue for fiscal 2026. Among the backlog are 15 projects each worth more than A$30 million, including one contract of A$730 million for which a decision is expected in the second half of this year.
Analyst views are divided. Bell Potter maintains a buy rating with a target of A$4.80, while Ord Minnett initiated coverage with a sell-equivalent “reduce” rating and a target of A$2.28, citing a potential slowdown in order momentum during the second half. The next major catalyst will be the half-year results due in August, when investors will look for clarity on both the ASIC probe and whether the company can convert its giant backlog into revenue. Until then, the stock remains trapped between record operational progress and a regulatory shadow that shows no sign of lifting.
Ad
DroneShield Stock: New Analysis - 19 June
Fresh DroneShield information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
